How a Smart Molecular Switch Could Revolutionize Cancer Immunotherapy Cutting-edge research from MIT and Stanford has opened a promising path in immunotherapy, offering hope for patients with cancers that have so far resisted treatment. The secret lies in a novel way to... antibody therapy biotechnology cancer research clinical trials glycans immune checkpoints immunotherapy
Yale’s Antibody-RNA Therapy: Tackling Treatment Resistant Cancers Recent advances at Yale are reshaping the fight against some of the toughest cancers. Researchers have engineered a unique antibody-RNA therapy that offers renewed hope for patients where traditional ... antibody-RNA cancer therapy clinical trials immunotherapy precision medicine resistant tumors Yale research
Roche's Trontinemab Raises the Bar for Alzheimer's Amyloid Clearance Alzheimer’s disease treatments may be on the cusp of a major breakthrough, thanks to Roche’s innovative antibody, trontinemab . This next-generation therapy has shown remarkable speed and effectivenes... Alzheimer’s amyloid plaques blood-brain barrier clinical trials drug development neurodegeneration trontinemab
Yale Once-Monthly Obesity Medication Is A Potential Treatment for Weight Loss For millions living with obesity and type 2 diabetes, medication adherence can be a constant struggle. Now, new research points to a future where a single monthly injection could replace the current w... clinical trials GLP-1 medications MariTide obesity pharmaceuticals type 2 diabetes weight loss Yale research
FDA’s Shift Away from Animal Testing: A New Era in Drug Development The pharmaceutical landscape is on the verge of a significant transformation as the FDA embarks on a journey to phase out animal testing in favor of innovative, human-relevant alternatives. This strat... animal testing biotechnology clinical trials drug development FDA organ chips pharmaceuticals